Tumor Drug Penetration Measurements Could Be the Neglected Piece of the Personalized Cancer Treatment Puzzle

Area of Science:

• Pharmacology and Oncology
• Translational Medicine
• Bioinformatics

Background:

• Precision medicine leverages patient-specific data (genomic, epigenomic, dosing) to improve treatment outcomes.
• Personalized dosing, guided by tumor drug penetration, is crucial for this approach.
• Current methods assess drug penetration through systemic exposure, tissue penetration, and cellular engagement.

Purpose of the Study:

• To review methodologies for measuring tumor drug penetration.
• To integrate in silico methods with experimental data to link dosing regimens with clinical outcomes.
• To provide a roadmap for implementing precision dosing in clinical practice.

Main Methods:

• Assessment of systemic drug exposure and tissue penetration.
• Evaluation of cellular or molecular target engagement and pharmacological activity.
• Integration of diverse data using in silico approaches to bridge pharmacokinetics and pharmacodynamics.

Main Results:

• Combined techniques offer enhanced patient-specific data on drug accessibility at the tumor site.
• Demonstrates improved understanding of target binding and downstream pharmacology.
• Highlights the potential for optimizing drug efficacy and minimizing toxicity.

Conclusions:

• Tumor drug penetration measurements are vital for precision dosing in oncology.
• Integrating multi-modal data provides a comprehensive view of drug action at the tumor level.
• This approach paves the way for personalized therapeutic strategies and improved patient outcomes.